哌库溴铵 | 68399-58-6

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 中文名称: 哌库溴铵
• 英文名称: Pipecuronium
• 英文别名: [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
• CAS: 68399-58-6
• 化学式: C35H62N4O4+2
• 分子量: 602.9
• InChiKey: OWWLUIWOFHMHOQ-XGHATYIMSA-N

物化性质

• 物理描述：
  Solid
• 溶解度：
  9.50e-05 g/L

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  43
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.94
• 拓扑面积：
  59.1
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• MULTIFUNCTIONAL SMALL MOLECULES
  申请人：Baker, JR. James R.

  公开号：US20120259114A1

  公开（公告）日：2012-10-11

  The present invention relates to dendrimer synthesis. Specifically, the present invention relates to triazine scaffolds capable of click chemistry for one-step synthesis of functionalized dendrimers, and methods of making and using the same.

  本发明涉及树枝状大分子的合成。具体而言，本发明涉及能够进行点击化学的 三嗪支架，用于一步法合成功能化树枝状大分子，以及制造和使用该支架的方法。
• [EN] ENVIRONMENT-FRIEND PROCESS FOR THE SYNTHESIS OF QUATERNARY AMMONIO-STERO?DS<br/>[FR] PROCEDE NON POLLUANT DE SYNTHESE D'AMMONIO-STEROIDES QUATERNAIRES
  申请人：RICHTER GEDEON VEGYESZET

  公开号：WO2006038047A1

  公开（公告）日：2006-04-13

  The invention relates to a new, environment-friend process for the synthesis of the known 4,4'-[3α,17β-bis(acetoxy)-5α-androstane-2β,l6β-diyl]-bis(l,l-dimethyl-ρiρerazinium) dibromide of formula (I) (from now on pipecuronium bromide) and l-[3α,17β-bis(acetoxy)-2β-(l-piperidinyl)-5α-androstane-16β-yl]-l-methyl-piperidinium bromide of formula (II) (from now on vecuronium bromide). Furthermore the invention relates to the new intermediates of formula (III) and formula (IV) of the process, wherein the meaning of X is benzenesulfonate - in given case para-substituted with a methyl or a nitro group or a bromine atom - methanesulfonate, ethanesulfonate or trifluoromethanesulfonate ion.

  该发明涉及一种新的、环保的合成过程，用于合成已知的化学式(I)的4,4'-[3α,17β-双(乙酰氧基)-5α-雄烷-2β,16β-二基]-双(1,1-二甲基-哌嗪)二溴化物（从现在开始称为哌库溴化物）和化学式(II)的l-[3α,17β-双(乙酰氧基)-2β-(1-哌啶基)-5α-雄烷-16β-基]-1-甲基-哌啶溴化物（从现在开始称为维库溴化物）。此外，该发明涉及该过程的新中间体的化学式(III)和化学式(IV)，其中X的含义是苯磺酸盐 - 在给定情况下对位取代为甲基、硝基或溴原子 - 甲磺酸盐、乙磺酸盐或三氟甲磺酸盐离子。
• [EN] SMALL MOLECULE ANTAGONISTS OF SUMO RELATED MODIFICATION OF CRMP2 AND USES THEREOF<br/>[FR] ANTAGONISTES À PETITES MOLÉCULES DE LA MODIFICATION LIÉE AU SUMO DE CRMP2 ET LEURS UTILISATIONS
  申请人：UNIV ARIZONA

  公开号：WO2018144900A1

  公开（公告）日：2018-08-09

  This invention is in the field of medicinal chemistry. In particular, the invention relates to a new class of small-molecules having a piperidinyl-benzoimidazole structure which function as antagonists of small ubiquitin like modifier (SUMO) related modification (SUMOylation) of collapsin response mediator protein 2 (CRMP2), and their use as therapeutics for the treatment of voltage gated sodium channel 1.7 (Nav1.7) related itch, anosmia, migraine event, and/or pain (e.g., neuropathic pain).

  这项发明属于药物化学领域。具体来说，该发明涉及一类具有哌啶基苯并咪唑结构的小分子，其作为小泛素样修饰物（SUMO）相关修饰（SUMOylation）的抗体，用作治疗与电压门控钠通道1.7（Nav1.7）相关的瘙痒、嗅觉丧失、偏头痛事件和/或疼痛（例如，神经病性疼痛）的治疗药物。
• PREPARATION AND UTILITY OF SUBSTITUTED CARBOXYLIC ACID COMPOUNDS
  申请人：Gant Thomas G.

  公开号：US20070276042A1

  公开（公告）日：2007-11-29

  The present disclosure is directed to modulators of cyclooxygenase (COX) enzymes and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and/or management of the severity and duration of non-specific pain, tension-type pain, headache, migraine, lower back pain, sciatica, dental pain, muscular pain, pain associated with acute soft tissue injuries, bursitis, tendonitis, lumbago, periarthritis, tennis elbow, sprains, strains, muscular problems associated with sports injuries, muscular problems associated with accidents, period pain, primary dysmenorrhoea, acute sore throat pain, osteoarthritis, rheumatoid arthritis, cancer, any disorder requiring analgesic response, any disorder requiring anti-inflammatory response, any disorder requiring antipyretic response, any conditions mediated by cyclooxygenase, cystic fibrosis, dementia, Alzheimer's disease, and/or conditions mediated by levels of β-amyloid are described.

  本公开涉及环氧合酶（COX）酶的调节剂及其药用盐和前药，其化学合成，以及这些化合物的医学用途，用于治疗和/或管理非特异性疼痛、紧张性疼痛、头痛、偏头痛、腰痛、坐骨神经痛、牙痛、肌肉疼痛、急性软组织损伤引起的疼痛、滑囊炎、肌腱炎、腰痛、周围关节炎、网球肘、扭伤、拉伤、与运动损伤相关的肌肉问题、与事故相关的肌肉问题、经期疼痛、原发性痛经、急性喉咙疼痛、骨关节炎、类风湿性关节炎、癌症、需要镇痛反应的任何疾病、需要抗炎反应的任何疾病、需要退热反应的任何疾病、任何通过环氧合酶介导的病症、囊性纤维化、痴呆、阿尔茨海默病和/或通过β-淀粉样蛋白水平介导的病症。
• PREPARATION AND UTILITY OF SUBSTITUTED ERYTHROMYCIN ANALOGS
  申请人：GANT Thomas G.

  公开号：US20070281894A1

  公开（公告）日：2007-12-06

  The present disclosure is directed to novel macrolide antibiotics of Formula 1 and pharmaceutically acceptable salts and prodrugs thereof; and the chemical syntheses and medical uses of these novel macrolide antibiotics for the treatment and/or management of infections caused by various aerobic and anaerobic gram-positive and gram-negative microorganisms as well as various mycobacteria.

  本公开涉及一种新型大环内酯抗生素的公式1及其药用可接受的盐和前药；以及这些新型大环内酯抗生素的化学合成和医学用途，用于治疗和/或管理由各种需氧和厌氧革兰氏阳性和阴性微生物以及各种分枝杆菌引起的感染。